Don't want ads? Subscribe or login now.

$5.5M Apotex Generic Drug Price-Fixing Deal Gets Initial OK

By Jared Foretek · May 16, 2024, 3:31 PM EDT

A Pennsylvania federal judge gave preliminary approval to yet another settlement in the sweeping generic drug price-fixing multidistrict litigation, this time signing off on pharmaceutical company Apotex's $5.5 million settlement with...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

2:16-md-02724

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016

Recent Articles By Jared

August 28, 2025
Mylan Must Face Generic Drug Price-Fixing Claims In MDL
August 01, 2025
J&J Unit's Catheter Rival Scores Injunction After $442M Win
July 15, 2025
GTCR Seeks Rival's Sales Data To Counter FTC Challenge
June 06, 2025
Judge Denies Class Cert. In Suit Over Unsolicited Faxes
June 02, 2025
Nursing Exec Says DOJ Misapplied Justices' Fraud Ruling
May 28, 2025
DOJ Says Justices' Ruling Backs Nursing Exec's Conviction
May 22, 2025
Justices Urged To Undo Denial Of Fast Track For Gastro Drug
May 22, 2025
EpiPen Direct Buyers, Mylan Get Final OK On Antitrust Deal
April 21, 2025
DOJ Defends Wage-Fixing Jury Win From Mistrial Bid
April 18, 2025
PBMs Press 8th Circ. Bid To Pause FTC Case